Видео ютуба по тегу Pliant Therapeutics

Minnie Kuo's COO Role: My Insight from Pliant Therapeutics Filing
Minnie Kuo's COO Role: My Insight from Pliant Therapeutics Filing
My Takeaway from PLRX's Leadership Resignation Filing
My Takeaway from PLRX's Leadership Resignation Filing
IPO PLIANT THERAPEUTICS (PLRX) | ОБЗОР-АНАЛИТИКА
IPO PLIANT THERAPEUTICS (PLRX) | ОБЗОР-АНАЛИТИКА
ACRP Clinical Trials Day Testimonial: Meghana Rao, CCRA, Pliant Therapeutics
ACRP Clinical Trials Day Testimonial: Meghana Rao, CCRA, Pliant Therapeutics
Pliant Therapeutics: My Take on the CMO's Departure
Pliant Therapeutics: My Take on the CMO's Departure
IPO Pliant Therapeutics и текущие дела
IPO Pliant Therapeutics и текущие дела
Обзор IPO компании Pliant Therapeutics Inc и наше решение / SharesPro
Обзор IPO компании Pliant Therapeutics Inc и наше решение / SharesPro
PLIANT THERAPEUTICS INC POTENTIAL BREAKOUT | PLRX STOCK NEWS
PLIANT THERAPEUTICS INC POTENTIAL BREAKOUT | PLRX STOCK NEWS
Pliant PLRX Biotech Stock, investing, Pliant Therapeutics, stocks to buy now,
Pliant PLRX Biotech Stock, investing, Pliant Therapeutics, stocks to buy now,
Mechanism of Action of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis (IPF)
Mechanism of Action of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis (IPF)
PLRX After-Hours Alert: Why Pliant Therapeutics Stock Is Moving
PLRX After-Hours Alert: Why Pliant Therapeutics Stock Is Moving
🔴 Pliant Therapeutics Inc PLRX Stock Information 🔴
🔴 Pliant Therapeutics Inc PLRX Stock Information 🔴
Безопасность и эффективность препарата PLN-74809 для лечения идиопатического легочного фиброза
Безопасность и эффективность препарата PLN-74809 для лечения идиопатического легочного фиброза
Как правильно инвестировать в IPO!, IPO Pliant Therapeutics и ZoomInfo Technologies разбор формы sec
Как правильно инвестировать в IPO!, IPO Pliant Therapeutics и ZoomInfo Technologies разбор формы sec
BEACON IPF Clinical Trial - Investigating the Slowing or Halting of Idiopathic Pulmonary Fibrosis
BEACON IPF Clinical Trial - Investigating the Slowing or Halting of Idiopathic Pulmonary Fibrosis
IBC 2024: Interview with Pliant Technologies
IBC 2024: Interview with Pliant Technologies
What's Next? - PLRX Stock Price Prediction - PLRX Stock Analysis | Pliant Therapeutics stock
What's Next? - PLRX Stock Price Prediction - PLRX Stock Analysis | Pliant Therapeutics stock
Cam Jones FX DAIILY ANALYSIS 606 (PLRX)(STOCK)(Pliant.Therapeutics.Inc)
Cam Jones FX DAIILY ANALYSIS 606 (PLRX)(STOCK)(Pliant.Therapeutics.Inc)
Safety and Efficacy of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis
Safety and Efficacy of PLN-74809 to Treat Idiopathic Pulmonary Fibrosis
Episode 133 - March 7, 2025
Episode 133 - March 7, 2025
2024 PSC Partners Annual Conference, Industry Updates: Ongoing PSC Clinical Trials
2024 PSC Partners Annual Conference, Industry Updates: Ongoing PSC Clinical Trials
ALYFTREK EU Nod, Winrevair FDA Review, IPF Updates & More
ALYFTREK EU Nod, Winrevair FDA Review, IPF Updates & More
PLRX Stock Update! Pliant Therapeutics Stock Prediction! PLRX Stock News! 7/12/2022
PLRX Stock Update! Pliant Therapeutics Stock Prediction! PLRX Stock News! 7/12/2022
Dr. Richard Gaster
Dr. Richard Gaster